Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Repligen Corporation (NASDAQ: RGEN) is a global life sciences company focused on the development and commercialization of innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. Their products are used by major biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) worldwide. Repligen's portfolio includes solutions for filtration, chromatography, process analytics, and protein products, critical for the production of monoclonal antibodies, gene therapies, and vaccines.
Serves as the global corporate hub, housing key administrative, research and development leadership, strategic planning, and executive management functions.
Modern office and lab facilities located within a prominent biotech and technology corridor. Designed to foster collaboration and innovation.
Characterized by a focus on scientific innovation, quality, customer-centricity, and collaboration. Employees are often driven by the impact of their work on advancing biopharmaceutical manufacturing and ultimately patient health.
The Waltham headquarters is central to Repligen's global strategy, R&D direction, and corporate governance. Its location in the Boston biotech hub provides access to talent, research institutions, and industry partners.
Repligen supports its global customer base through a network of manufacturing sites, R&D centers, commercial offices, and distribution partnerships across North America, Europe, and Asia. This strategic footprint enables localized customer support, timely product delivery, application development, and market-specific innovation in key biomanufacturing regions.
41 Seyon Street, Building 1, Suite 100
Waltham
Massachusetts
USA
Address: Scheelevägen 27, SE-223 63 Lund, Sweden
Supports European and global markets with advanced chromatography solutions and contributes significantly to Repligen's filtration and separation portfolio.
Address: Weingartshofer StraĂźe 25, 88214 Ravensburg, Germany
Major manufacturing and R&D hub for filtration technologies, serving the EMEA market and contributing to global supply.
Address: 18617 S Broadwick St, Rancho Dominguez, CA 90220, USA
Serves North American and global customers with filtration solutions, complementing other manufacturing sites.
Address: Minervum 7475, 4817 ZP Breda, Netherlands
Facilitates sales, distribution, and support for Repligen's products across Europe, enhancing customer service and market reach.
Address: Building 2, No. 690 Bibo Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China
Supports market development, sales, and customer service for Repligen's product portfolio in the APAC region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Repligen Corporation' leadership includes:
Repligen Corporation has been backed by several prominent investors over the years, including:
Repligen has made strategic appointments to its leadership team over the past year to strengthen its operational and commercial capabilities. Notable changes include additions to human resources and transitions within the board.
Discover the tools Repligen Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Repligen Corporation primarily uses the email format of the first initial followed by the last name. Variations might exist, but this is the most common structure.
f[last]@[repligen.com]
Format
thunt@repligen.com
Example
90%
Success rate
Yahoo Finance • May 7, 2024
Repligen Corporation reported first-quarter 2024 adjusted earnings per share that missed the Zacks Consensus Estimate. Revenues also lagged the consensus mark, impacted by challenging market conditions....more
GlobeNewswire • February 21, 2024
Repligen announced its financial results for the fourth quarter and full year ended December 31, 2023, highlighting revenue performance and providing an outlook for 2024....more
GlobeNewswire • January 9, 2024
Repligen announced preliminary unaudited revenue for the fourth quarter and full year 2023, and provided its initial financial guidance for the full year 2024, discussed at the J.P. Morgan Healthcare Conference....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Repligen Corporation, are just a search away.